BIOXCEL CORPORATION
BioXcel Corporation is a biotechnology firm using big data analytics and machine learning for drug development.
BIOXCEL CORPORATION
Industry:
Artificial Intelligence Biotechnology Life Science Machine Learning
Founded:
2005-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.bioxcel.com
Total Employee:
101+
Status:
Active
Contact:
203 957 2487
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Content Delivery Network Apache Google Apps For Business Cloudflare JS CDN JS
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
CIRECA LLC
Biotechnology AI company imaging by mid-IR radiation developing machine learning models of disease, normal, and immune response in tissue.
ZebiAI
ZebiAI is a platform that applies massive experimental DNA encoded library data sets to power machine learning for drug discovery.
Current Employees Featured
Founder
Official Site Inspections
http://www.bioxcel.com Semrush global rank: 7.6 M Semrush visits lastest month: 454
- Host name: 145.30.62.50.host.secureserver.net
- IP address: 50.62.30.145
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "BioXcel Corporation"
Bioxcel
In this position, Dave will work with senior leadership and the board of directors in the development and execution of strategy to drive significant growth within our organization. Prior …See details»
BioXcel Therapeutics Inc – BioXcel Therapeutics Inc
Nov 22, 2024 This web site is intended to help healthcare professionals practicing in the US find scientifically balanced, evidence-based information about Bioxcel Therapeutics drugs, submit …See details»
BioXcel Therapeutics - Crunchbase Company Profile
BioXcel Therapeutics is a clinical-stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. Its drug re …See details»
Overview – BioXcel Therapeutics Inc
BioXcel Therapeutics employs a unique AI platform to reduce therapeutic development costs and potentially accelerate timelines while aiming to increase the possibility of success. Our approach leverages existing approved drugs …See details»
Board of Directors – BioXcel Therapeutics Inc
In 2006, Dr. Mehta co-founded BioXcel LLC, which pioneered the application of big data analytics and machine learning-based AI integrated with drug-development expertise. In 2017, he co …See details»
BioXcel Corporation - Crunchbase Company Profile & Funding
PharmiWeb.com — Cloud Based Drug Discovery Platform Market | Accenture PLC, BioXcel Corporation, Cloud Pharmaceuticals, Inc., WuXi AppTec | By 2032 News • Dec 13, 2022 …See details»
2021 ANNUAL REPORT - BioXcel Therapeutics
BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE 12TH FLOOR NEW HAVEN, CT 06511 T 475 238 6837 WWW.BIOXCELTHERAPEUTICS.COM . EXECUTIVE OFFICERS ...See details»
BioXcel Therapeutics - Contacts, Employees, Board Members, …
BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence. Search Crunchbase Start Free TrialSee details»
BioXcel Therapeutics, Inc. | LinkedIn
BioXcel Therapeutics, Inc. | 9,501 followers on LinkedIn. Developing transformative medicines in neuroscience using artificial intelligence approaches | Biopharmaceutical company developing ...See details»
BioXcel Company Profile - Office Locations, Competitors ... - Craft
BioXcel Corporation is a biopharmaceutical company focusing on the application of artificial intelligence and big data analytics integrated with drug development expertise. It develops …See details»
BioXcel Therapeutics Appoints June Bray to Board of Directors
“I am excited to join BioXcel’s Board as the Company prepares to transition to a commercial-stage organization,” said June Bray. “I truly believe BioXcel’s strong neuroscience program has the …See details»
Executive Officers – BioXcel Therapeutics Inc
In 2006, Dr. Mehta co-founded BioXcel LLC, which pioneered the application of big data analytics and machine learning-based AI integrated with drug-development expertise. In 2017, he co …See details»
BioXcel Therapeutics Announces $260 Million Strategic
Apr 19, 2022 BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno …See details»
BioXcel Therapeutics Announces Promising Topline Results from …
May 25, 2023 BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno …See details»
BioXcel Therapeutics Announces FDA Acceptance for Filing of
May 19, 2021 BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and …See details»
Our Pipeline – BioXcel Therapeutics Inc
Aug 14, 2023 BioXcel Therapeutics believes BXCL501 potentially targets an important mediator of agitation and has observed anti-agitation results in multiple clinical trials across several …See details»
BioXcel Therapeutics Announces Positive Top-Line Data from …
Jun 1, 2021 BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno …See details»
BioXcel Therapeutics Receives FDA Breakthrough Therapy
Mar 15, 2021 BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and …See details»
Antibodies for In Vivo Research | Bio X Cell
In vivo Antibodies Explore the largest catalog of antibodies specifically formulated for in vivo use.; Isotype Controls Clearly identify antibody-specific signals with matching isotype controls ready …See details»
Advisors – BioXcel Therapeutics Inc
She most recently served as Chief Medical Officer of Receptos, an immunology-focused biotechnology company acquired by Celgene in 2015 for $7.2 billion. At Receptos, she built …See details»